Document is current
Any future updates will be listed below
-
Authors
Bergam, Scarlett https://orcid.org/0000-0001-6550-8508
Sibaya, Thobekile
Ndlela, Nompumelelo
Kuzwayo, Mpume
Fomo, Messaline
Goldstein, Madeleine H.
Marconi, Vincent C.
Haberer, Jessica E.
Archary, Moherndran
Zanoni, Brian C.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K23MH114771)
Center for AIDS Research, Emory University (P30AI050409)
Fulbright Association
National Institute of Health, National Institute of Mental Health (K24MH114732)
- License Information
-
More Information
Article History
Received: 4 March 2022
Accepted: 21 October 2022
First Online: 1 December 2022
Declarations
:
: Ethical approval was obtained from the Institutional Review Board (IRB) at Emory University in the USA and the Biomedical Research Ethics Committee (BREC) the University of KwaZulu-Natal in South Africa (Reference number BFC057/18).All participants provided written informed assent if under 18 and written informed consent if over 18. A caregiver also provided written informed consent if their adolescent was under 18. All consent and assent forms were read to the participants in their chosen language (isiZulu or English), and participants were given the opportunity to ask questions to ensure their understanding.
: All participants gave consent for publication.
: VCM reports research grants from the CDC, Gilead Sciences, NIH, Veterans Affairs, and ViiV Healthcare; honoraria from Eli Lilly and Company; has served as an advisory board member for Eli Lilly and Company and Novartis; and has participated as a study section chair for the NIH. JEH has been a paid consultant for Merck. The remaining authors have no conflicts of interest to disclose.
